AN ACT relating to health care services provided in clinical trials for the treatment of cancer.
     Create a new section of Subtitle 17A of KRS Chapter 304 to prohibit a health benefit plan from excluding coverage for routine patient healthcare costs that are incurred in the course of a cancer clinical trial if the health benefit plan would provide coverage for the routine patient healthcare cost had it not been incurred in a cancer clinical trial; provide that nothing in this section requires a policy to offer, nor prohibit a policy from offering, cancer clinical trial services by a participating provider; provide that nothing in this section requires services that are performed in a cancer clinical trial by a non-participating provider of a policy to be reimbursed at the same rate as those performed by a participating provider of the policy.

     (Prefiled by the sponsor(s).)

     Nov 4-To: Interim Joint Committee on Banking and Insurance
     Jan 5-introduced in Senate
     Jan 6-to Banking & Insurance (S)
     Feb 2-reported favorably, 1st reading, to Calendar
     Feb 3-2nd reading, to Rules
     Feb 9-posted for passage in the Regular Orders of the Day for Wednesday, February 10, 2010
     Feb 10-3rd reading, passed 36-0; received in House
     Feb 12-to Banking & Insurance (H)
     Feb 26-posted in committee
     Mar 3-reported favorably, 1st reading, to Calendar
     Mar 4-2nd reading, to Rules
     Mar 5-posted for passage in the Regular Orders of the Day for Monday, March 8, 2010
     Mar 11-3rd reading, passed 96-0
     Mar 12-received in Senate
     Mar 15-enrolled, signed by President of the Senate
     Mar 16-enrolled, signed by Speaker of the House; delivered to Governor
     Mar 24-signed by Governor (Acts ch. 23)